Indian firm unveils latest typhoid shots

An Indian pharmaceutical firm said Thursday it would soon launch the world's first vaccine against typhoid which can be given to infants, protecting the most vulnerable victims of the illness.

Bharat Biotech, based in the southern city of Hyderabad, said it would also offer long-term protection of more than 10 years, unlike other vaccines which must be boosted with regular injections.

"This is the world's first clinically-proven vaccine for children of six months and above," spokeswoman Sheela Panicker told AFP.

The World Health Organisation says the food- and water-borne disease kills 600,000 people a year and infects an estimated 17 million, mainly children. Ninety percent of such cases are reported in Asia.

"Available typhoid vaccines do not offer long-term protection and booster doses are required every three years, and also they do not offer protection to children aged below two years," Panicker added.

Indian have given their go-ahead to the "fourth-generation" vaccine, which can also be taken by adults, and it is expected to be launched in the next two weeks.

Panicker said the firm would decide its cost depending on the volume after its launch. Production capacity was currently 10 million doses per year, she said.

In May Biotech unveiled a low-cost vaccine against a deadly diarrhoea-causing virus that kills some 100,000 children in India every year.

Rotavirus, which causes severe diarrhoea, is globally responsible for some 453,000 deaths annually and is particularly dangerous in the developing world where swift health care is often out of reach.

India has also been a powerhouse in developing to treat diseases such as cancer, tuberculosis and AIDS for those who cannot afford expensive branded versions across the developing world.

add to favorites email to friend print save as pdf

Related Stories

India announces low-cost rotavirus vaccine (Update)

May 14, 2013

The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.

Pfizer sells key vaccine cheaply to poor countries

Jul 29, 2013

Drugmaker Pfizer Inc. has agreed to provide hundreds of millions of doses of its lucrative vaccine against pneumonia and meningitis at a fraction of the usual price for young children in poor countries.

Rotavirus vaccine given to newborns in Africa is effective

Jun 17, 2013

Mayo Clinic and other researchers have shown that a vaccine given to newborns is at least 60 percent effective against rotavirus in Ghana. Rotavirus causes fever, vomiting and diarrhea, which in infants can cause severe dehydration. ...

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

Nov 20, 2014

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

Nov 20, 2014

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

Nov 20, 2014

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.